Overview

Effect of Vigabatrin in Refractory Autoimmune Encephalitis Patients

Status:
Withdrawn
Trial end date:
2020-09-09
Target enrollment:
Participant gender:
Summary
Investigation of efficacy of vigabatrin in refractory autoimmune encephalitis patients
Phase:
N/A
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Vigabatrin